Raleigh, NC (July 20, 2016) — Contego Medical, LLC announced today that it has completed enrollment in the Paladin® Carotid PostDilation Balloon System Registry in Europe. The registry involved 5 centers with 100 total patients, and represents the first prospective clinical evaluation of a new class of device that provides Integrated Embolic Protection™ (IEP) technology for interventional treatment of carotid stenosis.
Contego Medical Announces Positive Clinical Data for Paladin® System, the First Post-Dilation Balloon with Integrated Embolic Protection™ Technology
Data presented at the Leipzig Interventional Course (LINC) demonstrates breakthrough treatment for Carotid Artery Disease
Raleigh, NC (January 26, 2016) — Contego Medical, an innovator in developing next generation treatments for coronary and peripheral artery disease, today presented positive post-market registry data for the Paladin® Carotid Post-Dilation Balloon with Integrated Embolic Protection™ (IEP) Technology at LINC 2016, in Leipzig, Germany. The presentation included compelling results from a diffusion-weighted MRI (DW-MRI) sub-study that showed improved patient outcomes with the Paladin System.
Contego Medical Announces European Commercialization of the Paladin® Carotid Post-Dilation Balloon with Integrated Embolic Protection™ Technology
Presenting at the Leipzig Interventional Course (LINC) from January 26th-29th in Leipzig, Germany. RALEIGH, NC. (January 14, 2016) – Contego Medical today announced the European commercialization of the Paladin® Carotid Post-Dilation Balloon, the first and only angioplasty balloon with Integrated Embolic Protection™ (IEP) Technology for patients undergoing carotid stenting procedures. The innovative IEP platform, which combines embolic protection and treatment into one device, is designed to simplify the procedure and improve patient outcomes.
Raleigh, NC (April 17, 2015) – Contego Medical, the first and only provider of the Integrated Embolic ProtectionTM filter platform for angioplasty balloon and stent delivery catheters, announces the completion of a $5.6 million Series B financing round led by Hatteras Venture Partners, an early stage venture firm with a focus on medical devices, biopharmaceuticals, diagnostics and related opportunities in human medicine. The round also included Mountain Group Partners, Lookout Capital and Medical Mutual.